Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Tepadina

TEPADINA 200 mg powder and solvent for solution for infusion TEPADINA 400 mg powder and solvent for solution for infusion · Abschnitt 4.8 · PDF-Seite 27

HOS-210436 · Präparat HOS-154509

Immune Acute graft versus Hypersensitivity system host disease disorders Chronic graft versus host disease Endocrine Hypopituitarism disorders Metabolism Anorexia and nutrition Decreased disorders appetite Hyperglycaemia Psychiatric Confusional state Anxiety Delirium disorders Mental status Nervousness changes Hallucination Agitation Nervous Dizziness Intracranial Leukoencephalopath system Headache aneurysm y disorders Vision blurred Extrapyramidal Encephalopathy disorder Convulsion Cognitive disorder Paraesthesia Cerebral haemorrhage Eye disorders Conjunctivitis Cataract Ear and Hearing impaired labyrinth Ototoxicity disorders Tinnitus Cardiac Arrhythmia Tachycardia Cardiomyopath disorders Cardiac failure y Myocarditis Vascular Lymphoedema Haemorrhage disorders Hypertension Embolism Respiratory, Idiopathic Pulmonary Hypoxia thoracic and pneumonia oedema mediastinal syndrome Cough disorders Epistaxis Pneumonitis Gastrointestina Nausea Constipation Gastrointestinal l disorders Stomatitis Gastrointestinal ulcer Oesophagitis perforation Vomiting Ileus Diarrhoea Dyspepsia Abdominal pain Enteritis Colitis Hepatobiliary Venoocclusive disorders liver disease Hepatomegaly Jaundice Skin and Rash Erythema Pigmentation Severe toxic skin subcutaneous Pruritus disorder reactions including tissue disorders Alopecia Erythrodermic cases of Stevens- psoriasis Johnson syndrome

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.